Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence

AIMS: Raloxifene treatment of osteoporotic fractures is clinically effective, but economic evidence in support of raloxifene reimbursement is lacking in the People’s Republic of China. We aimed at evaluating the cost-effectiveness of raloxifene in the treatment of osteoporotic fractures using an ost...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mingsheng, Si, Lei, Winzenberg, Tania M, Gu, Jieruo, Jiang, Qicheng, Palmer, Andrew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820231/
https://www.ncbi.nlm.nih.gov/pubmed/27099477
http://dx.doi.org/10.2147/PPA.S100175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820231/
https://www.ncbi.nlm.nih.gov/pubmed/27099477
http://dx.doi.org/10.2147/PPA.S100175

Ejemplares similares